Skip to main content

Advertisement

SpringerLink
Log in

Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction and objectives

To evaluate retrospectively kidney-specific cadherin (Ksp-cad) expression in renal cell carcinoma (RCC) subtypes and oncocytoma in correlation with its ontogenetic origin of distal and proximal tubules and to correlate Ksp-cad expression with tumour characteristics.

Materials and methods

Membranous and cytoplasmic expression of Ksp-cad was determined in 40 clear cell (ccRCC), 25 papillary (pRCC), 19 chromophobe carcinomas (chRCC), 27 oncocytomas (oncocytomas) (n = 111) and 32 benign kidney parenchyma specimens separated in distal tubules (DT) and proximal tubules (PT) by immunohistochemistry using tissue microarray technique. Staining intensity was quantified as a score ranging from 0 to 12. Comparison of data and correlation with tumour characteristics were done by Wilcoxon/Kruskal–Wallis tests (post hoc Tukey–Kramer analysis).

Results

In benign renal tissue, membranous and cytoplasmic expression of Ksp-cad in the DT was significantly higher than that in the PT (12.0 ± 0 vs. 5.2 ± 0.3 and 6.3 ± 0.5 vs. 0.0 ± 0.0, respectively; (P < 0.05)). Membranous KSP-cad expression was significantly higher in chRCC (5.2 ± 0.8) and oncocytomas (3.7 ± 0.4) than that in ccRCC (0.8 ± 0.2) and pRCC (1.4 ± 0.4; P < 0.05), while expression between oncocytomas and chRCC did not differ significantly. In RCC, Ksp-cad expression was significantly associated with higher T stage and the occurrence of synchronous metastasis (P < 0.05). Higher N stages and grading tended to correlate with a lower Ksp-cad expression.

Conclusions

In this cohort, the origin of tumour subtypes—chRCC and oncocytomas develop from DT and ccRCC and pRCC from PT cells—is mirrored by the respective Ksp-cad expression. This raises the question whether DT-derived tumours have a less malignant potential than PT-derived tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ljungberg B et al (2007) Renal cell carcinoma guideline. Eur Urol 51:1502–1510

    Article  PubMed  Google Scholar 

  2. Bedke J, Stenzl A (2010) Renal cell carcinoma: recent developments in diagnostics and therapy. Urologe A 49(Suppl 1):178–184

    Article  PubMed  Google Scholar 

  3. Thedieck C et al (2005) Expression of Ksp-cadherin during kidney development and in renal cell carcinoma. Br J Cancer 92:2010–2017

    Article  PubMed  CAS  Google Scholar 

  4. Heicappell R (1999) Cadherins in renal cell carcinoma. Anticancer Res 19:1501–1504

    PubMed  CAS  Google Scholar 

  5. Thomson RB et al (1998) cDNA cloning and chromosomal localization of the human and mouse isoforms of Ksp-cadherin. Genomics 51:445–451

    Article  PubMed  CAS  Google Scholar 

  6. Adley BP et al (2006) Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 126:79–85

    Article  PubMed  CAS  Google Scholar 

  7. Mazal PR et al (2005) Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum Pathol 36:22–28

    Article  PubMed  CAS  Google Scholar 

  8. Shen SS et al (2005) Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related renal neoplasms. Mod Pathol 18:933–940

    Article  PubMed  CAS  Google Scholar 

  9. Thoenes W, Rumpelt HJ, Storkel S (1990) Classification of renal cell carcinoma/tumors and their relationship to the nephron-collecting tubules system. Klin Wochenschr 68:1102–1111

    Article  PubMed  CAS  Google Scholar 

  10. Kononen J et al (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    Article  PubMed  CAS  Google Scholar 

  11. Eble JN (2004) Pathology and genetics of tumours of the urinary system and male genital organs. In: Eble JN, Sauter G, Epstein JI (eds) World health organisation classification of tumours. IARC Press, Lyons, p 7

    Google Scholar 

  12. Sobin LH, Ce W (2002) TNM classification of malignant tumours (UICC), 6th edn. Wiley Liss-CH, New York

    Google Scholar 

  13. Kramer MW et al (2007) Tissue microarrays in clinical urology–technical considerations. Scand J Urol Nephrol 41:478–484

    Article  PubMed  CAS  Google Scholar 

  14. Merseburger AS et al (2006) Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma. Urologe A 45(323–324):326–327

    Google Scholar 

  15. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140

    PubMed  CAS  Google Scholar 

  16. Gakis G et al (2010) Small renal oncocytomas: differentiation with multiphase CT. Eur J Radiol. doi:10.1016/j.ejrad.2010.06.049

  17. Remzi M, Marberger M (2009) Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol 55:359–367

    Article  PubMed  Google Scholar 

  18. Rao Q et al (2007) Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance. Zhonghua Bing Li Xue Za Zhi 36:15–18

    PubMed  Google Scholar 

  19. Thedieck C et al (2008) Alpha B-crystallin is a cytoplasmic interaction partner of the kidney-specific cadherin-16. J Mol Biol 378:145–153

    Article  PubMed  CAS  Google Scholar 

  20. Cavallaro U, Christofori G (2004) Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4:118–132

    Article  PubMed  CAS  Google Scholar 

  21. Imai T et al (2003) Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163:1437–1447

    Article  PubMed  CAS  Google Scholar 

  22. Russell RC, Ohh M (2007) The role of VHL in the regulation of E-cadherin: a new connection in an old pathway. Cell Cycle 6:56–59

    Article  PubMed  CAS  Google Scholar 

  23. Brembeck FH, Rosario M, Birchmeier W (2006) Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16:51–59

    Article  PubMed  CAS  Google Scholar 

  24. Barnes EA et al (2010) Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition. Am J Pathol 177:1765–1778

    Article  PubMed  CAS  Google Scholar 

  25. Horwitz J (2000) The function of alpha-crystallin in vision. Semin Cell Dev Biol 11:53–60

    Article  PubMed  CAS  Google Scholar 

  26. Michl M et al (2006) Expression and regulation of alphaB-crystallin in the kidney in vivo and in vitro. Pflugers Arch 452:387–395

    Article  PubMed  CAS  Google Scholar 

  27. Singh BN et al (2007) Association of alphaB-crystallin, a small heat shock protein, with actin: role in modulating actin filament dynamics in vivo. J Mol Biol 366:756–767

    Article  PubMed  CAS  Google Scholar 

  28. Ghosh JG, Shenoy AK Jr, Clark JI (2007) Interactions between important regulatory proteins and human alphaB crystallin. Biochemistry 46:6308–6317

    Article  PubMed  CAS  Google Scholar 

  29. Amin MB et al (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281–291

    Article  PubMed  Google Scholar 

  30. Moch H et al (2000) Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 89:604–614

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors have nothing to declare.

Author information

Author notes

  1. M. Horstmann

    Present address: Department of Urology, Kantonsspital Winterthur, Brauerstr. 15, 8401, Winterthur, Switzerland

Authors and Affiliations

  1. Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen, Germany

    M. Horstmann, L. M. Geiger, J. Hennenlotter, U. Kuehs, S. Kruck, A. Stenzl & J. Bedke

  2. Department of Urology and Urologic Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany

    A. S. Merseburger

  3. Institute of Pathology, Eberhard Karls University Tuebingen, Hoppe–Seyler-Str. 3, 72076, Tuebingen, Germany

    U. Vogel

  4. Interfaculty Institute for Biochemistry, University of Tuebingen, Hoppe-Seyler-Str. 4, 72076, Tuebingen, Germany

    H. Schmid

Authors
  1. M. Horstmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Geiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U. Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Hennenlotter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. U. Kuehs
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. S. Merseburger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S. Kruck
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Stenzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J. Bedke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to M. Horstmann or J. Bedke.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 40 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horstmann, M., Geiger, L.M., Vogel, U. et al. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?. World J Urol 30, 525–531 (2012). https://doi.org/10.1007/s00345-011-0763-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-011-0763-3

Keywords

Search

Navigation